Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3179-3188

  Kanesa Thasan, N ^a   Sun, W ^a   Kim Ahn, G ^b   Van Albert, S ^a   Putnak, J R ^a   King, A ^a   Raengsakulsrach, B ^c   Christ Schmidt, H ^d   Gilson, K ^a   Zahradnik, J M ^e   Vaughn, D W ^c   Innis, B L ^a   Saluzzo, J F ^e   Hoke Jr, C H ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d University of Iowa   (United States)

^e SANOFI PASTEUR   (France)

Author keywords

Dengue; Tetravalent; Vaccine; Virus

Indexed keywords

DENGUE VACCINE; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HUMAN; IMMUNOGENICITY; MALAISE; MALE; NEUTROPENIA; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRAIN DIFFERENCE; VIREMIA; VIRUS STRAIN;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; SAFETY; VACCINES, ATTENUATED; VIRAL VACCINES; VIREMIA;

EID: 0035971965     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00020-2     Document Type: Article

References (21)

1. Dengue: The risk to developed and developing countries
2. Dengue and dengue haemorrhagic fever
3. Dengue and dengue hemorrhagic fever: Its history and resurgence as a global public health problem
4. New and improved vaccines for dengue, Japanese encephalitis, and yellow fever viruses
5. Live attenuated tetravalent dengue vaccine
6. Dengue and dengue hemorrhagic fever
7. Dengue-2 vaccine: Preparation from a small-plaque virus clone
8. Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3′-noncoding region universal primers
9. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate
10. A plaque reduction test for dengue virus neutralization antibodies
11. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans
12. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): Clinical, immunological and biological responses in adult volunteers
13. Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers
14. Study of bivalent dengue vaccine in volunteers
15. Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans
16. Live attenuated tetravalent dengue vaccine
17. In vitro homotypic and heterotypic interference by defective interfering particles of West Nile virus
18. Randomised trial of alternative formulations of oral poliovaccine in Brazil
19. Dengue 2 vaccine: Dose response in volunteers in relation to yellow fever immune status
20. Human T cell responses to dengue antigens. Proliferative responses and interferon gamma production